Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioClinica Launches StudyView | Contract Pharma
Breaking News

BioClinica Launches StudyView

Reporting hub designed to increase clinical trials operational visibility

BioClinica, Inc. has introduced StudyView, a clinical trials portal and reporting hub designed to increase clinical trials operational visibility. StudyView provides one tool to access multiple eClinical applications, as well as analyze and report data across studies. StudyView is fully integrated with BioClinica’s product suite and is 21 CFR Part 11 compliant. 

StudyView leverages Microsoft business intelligence technologies such as Power View to create interactive dashboards and SQL Server Reporting Services (SSRS), enabling users to build a range of summary and granular reports and surface them in SharePoint 2013 to support further analysis and action. According to the company, StudyView is a clean, modern portal that eliminates the need for multiple logins and data flows seamlessly between applications.

“Achieving real-time operational visibility of clinical studies data can be difficult, especially when multiple systems are involved,” said Peter Benton, BioClinica’s president of e-Clinical Solutions. “Now you can get the answers to critical clinical study operations questions in one place. This is the kind of cross-system operational metrics visibility that is a necessary cornerstone of any risk-based monitoring plan.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters